Abstract
N-[3-[[[(1S)-4-(5-Amino-2-pyridinyl)-1-[[4-difluoromethylene)-1-piperidinyl]carbonyl]butyl]amino]sulfonyl][1,1′-biphenyl]-2-yl]acetamide hydrochloride (SSR182289A) is a novel, potent, and selective thrombin inhibitor. We have examined the antithrombotic properties of SSR182289A administered by i.v. and p.o. routes in several different animal thrombosis models in comparison with reference antithrombotic agents. Oral administration of SSR182289A produced dose-related antithrombotic effects in the following models; rat venous thrombosis (ED50 0.9 mg/kg p.o.), rat silk thread arterio-venous (AV) shunt (ED50 3.8 mg/kg p.o.), rat thromboplastin-induced AV shunt (ED50 3.1 mg/kg p.o.), rat carotid artery thrombosis (ED200 5.9 mg/kg p.o.), and rabbit venous thrombosis (ED50 7.5 mg/kg p.o.). Administered as an i.v. bolus, SSR182289A showed antithrombotic activity in the above models with ED50/ED200 values in the range of 0.2 to 1.9 mg/kg i.v. SSR182289A increased rat tail transection bleeding time at doses ≥10 mg/kg p.o. In the rat thromboplastin-induced AV shunt model, SSR182289A 10 mg/kg p.o. produced marked antithrombotic effects at 30, 60, 120, and 240 min after administration. Hence, SSR182289A demonstrates potent oral antithrombotic properties in animal venous, AV-shunt, and arterial thrombosis models.
Footnotes
-
DOI: 10.1124/jpet.102.044610
- Abbreviations:
- SSR182289A
- N-[3-[[[(1S)-4-(5-amino-2-pyridinyl)-1-[[4-difluoromethylene)-1-piperidinyl]carbonyl]butyl]amino]sulfonyl][1,1′- biphenyl]-2-yl]acetamide hydrochloride
- AV shunt
- arterio-venous shunt
- SR90107
- fondaparinux
- DX9065a
- (+)-(2S)-2-[4-[[(3S)-1-acetimidoyl-3-pyrrolidinyl]oxo]phenyl]-3-[7-amidino-2-naphthyl]propanoic acid hydrochloride pentahydrate
- CI
- 95% confidence intervals
- Received September 19, 2002.
- Accepted October 17, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|